Immatics (IMTX) had the highest return between 2015 and 2019 by a US stock in the Biotechnology Industry, returning 207,900%.

ASSET	YEARS	% RETURN
Immatics (IMTX)	2015-2019	207,900%
GeoVax Labs (GOVX)	2015-2019	120,301.34%
GT Biopharma (GTBP)	2015-2019	117,928.57%
AquaBounty Technologies (AQB)	2015-2019	30,038.89%
Amarin (AMRN)	2015-2019	2,087.76%
Exelixis (EXEL)	2015-2019	1,098.64%
Galapagos NV ADR (GLPG)	2015-2019	991.11%
Evotec SE ADR (EVO)	2015-2019	975.13%
Theratechnologies (THTX)	2015-2019	964.52%
argenx NV ADR (ARGX)	2015-2019	796.76%
Sarepta Therapeutics (SRPT)	2015-2019	785.05%
Arrowhead Pharmaceuticals (ARWR)	2015-2019	722.7%
Avita Medical (RCEL)	2015-2019	622.22%
Kodiak Sciences (KOD)	2015-2019	619.5%
Ascendis Pharma A-S (ASND)	2015-2019	547.07%
BeiGene (ONC)	2015-2019	472.18%
Vericel Corp Ord (VCEL)	2015-2019	470.49%
Dyadic International (DYAI)	2015-2019	451.06%
Krystal Biotech (KRYS)	2015-2019	427.43%
Aurinia Pharmaceuticals (AUPH)	2015-2019	411.62%
Matinas BioPharma (MTNB)	2015-2019	404.44%
DiaMedica Therapeutics (DMAC)	2015-2019	394.9%
Cidara Therapeutics (CDTX)	2015-2019	380%
Uniqure (QURE)	2015-2019	377.73%
Neurocrine Biosciences (NBIX)	2015-2019	375.83%